A detailed history of Jump Financial, LLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Jump Financial, LLC holds 307,171 shares of FOLD stock, worth $3.1 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
307,171
Previous 47,965 540.41%
Holding current value
$3.1 Million
Previous $475,000 590.53%
% of portfolio
0.07%
Previous 0.01%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$9.55 - $12.09 $2.48 Million - $3.13 Million
259,206 Added 540.41%
307,171 $3.28 Million
Q2 2024

Aug 14, 2024

SELL
$9.04 - $11.75 $441,287 - $573,576
-48,815 Reduced 50.44%
47,965 $475,000
Q1 2024

May 13, 2024

SELL
$11.43 - $14.24 $1.32 Million - $1.65 Million
-115,521 Reduced 54.41%
96,780 $1.14 Million
Q4 2023

Oct 21, 2024

SELL
$9.97 - $14.52 $250,127 - $364,277
-25,088 Reduced 10.57%
212,301 $3.01 Million
Q4 2023

Feb 07, 2024

SELL
$9.97 - $14.52 $250,127 - $364,277
-25,088 Reduced 10.57%
212,301 $3.01 Million
Q3 2023

Oct 21, 2024

BUY
$11.78 - $13.86 $1.81 Million - $2.12 Million
153,282 Added 182.25%
237,389 $2.89 Million
Q3 2023

Nov 07, 2023

BUY
$11.78 - $13.86 $1.81 Million - $2.12 Million
153,282 Added 182.25%
237,389 $2.89 Million
Q2 2023

Oct 21, 2024

SELL
$10.72 - $13.3 $895,548 - $1.11 Million
-83,540 Reduced 49.83%
84,107 $1.06 Million
Q2 2023

Aug 07, 2023

SELL
$10.72 - $13.3 $895,548 - $1.11 Million
-83,540 Reduced 49.83%
84,107 $1.06 Million
Q1 2023

Oct 21, 2024

BUY
$10.91 - $13.54 $1.31 Million - $1.62 Million
119,682 Added 249.52%
167,647 $1.86 Million
Q1 2023

May 03, 2023

BUY
$10.91 - $13.54 $1.83 Million - $2.27 Million
167,647 New
167,647 $1.86 Million
Q3 2022

Nov 07, 2022

BUY
$9.82 - $12.75 $319,150 - $414,375
32,500 Added 45.14%
104,500 $1.09 Million
Q2 2022

Aug 09, 2022

SELL
$6.23 - $11.12 $514,809 - $918,890
-82,634 Reduced 53.44%
72,000 $773,000
Q1 2022

May 12, 2022

BUY
$7.89 - $12.48 $927,966 - $1.47 Million
117,613 Added 317.69%
154,634 $1.46 Million
Q4 2021

Feb 10, 2022

BUY
$9.82 - $12.44 $363,546 - $460,541
37,021 New
37,021 $428,000
Q2 2021

Aug 13, 2021

SELL
$8.71 - $10.72 $713,436 - $878,075
-81,910 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$9.2 - $23.86 $753,572 - $1.95 Million
81,910 New
81,910 $810,000

Others Institutions Holding FOLD

About AMICUS THERAPEUTICS, INC.


  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $2.83B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Jump Financial, LLC Portfolio

Follow Jump Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.